Gastrointestinal tolerance to an inulin-rich soluble roasted chicory extract after consumption in healthy subjects

Abstract Objectives We aimed to assess in healthy subjects 1) the effect of two doses of a new naturally inulin-rich soluble chicory extract (IRSCE) on overall gastrointestinal discomfort after short-term ingestion and 2) the effect on gastrointestinal symptoms of long-term consumption of IRSCE admi...

Full description

Saved in:
Bibliographic Details
Published inNutrition (Burbank, Los Angeles County, Calif.) Vol. 26; no. 7; pp. 799 - 803
Main Authors Ripoll, Christophe, Ph.D, Flourié, Bernard, M.D., Ph.D, Megnien, Sophie, M.D, Hermand, Olivier, D.M.D, Janssens, Myriam, M.Sc
Format Journal Article
LanguageEnglish
Published New York, NY Elsevier Inc 01.07.2010
[New York]: Elsevier Science Inc
Elsevier
Elsevier Limited
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Objectives We aimed to assess in healthy subjects 1) the effect of two doses of a new naturally inulin-rich soluble chicory extract (IRSCE) on overall gastrointestinal discomfort after short-term ingestion and 2) the effect on gastrointestinal symptoms of long-term consumption of IRSCE administered at a dose compatible with its future commercial use. Methods First, the effect of IRSCE was assessed on overall gastrointestinal discomfort in a double-blind, crossover study where 18 subjects received in a randomized order a morning coffee drink including 10 g of sucrose alone (control period) or with IRSCE at two doses (8.9 and 14.0 g containing 5.0 and 7.8 g of inulin, respectively) during three consecutive 6-d periods. Second, 35 subjects were followed during a randomized, double-blind protocol where they were asked to take twice a day an instant coffee drink containing IRSCE (8.1 g/d containing inulin 5.0 g/d) or sucrose 8.1 g/d during 4 wk. The effects of the treatment on flatulence, bloating, abdominal pain, stool consistency, and number were recorded. Results In the first study a significant slight increase ( P = 0.05) in overall abdominal discomfort was observed with the morning coffee drink containing 7.8 g of inulin after 1 wk of consumption. In the second study, no significant differences between the IRSCE and placebo groups were evidenced with respect to gastrointestinal symptoms during the consumption period. Conclusion Short- and long-term consumptions of IRSCE, given at a daily dose containing 5 g of inulin, are well tolerated by healthy subjects.
Bibliography:http://dx.doi.org/10.1016/j.nut.2009.07.013
ISSN:0899-9007
1873-1244
DOI:10.1016/j.nut.2009.07.013